| Jonathan Paul Berry, MD | |
|
209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 | |
| (253) 596-3300 | |
| (253) 596-3301 |
| Full Name | Jonathan Paul Berry |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Emergency Medicine |
| Location | 209 Martin Luther King Jr Way, Tacoma, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194119115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ML60562628 (Washington) | Secondary |
| 2080P0204X | Pediatrics - Pediatric Emergency Medicine | MD60847137 (Washington) | Primary |
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the degree of aggressiveness of the tumour in the early stages and can thus devise an individualised treatment plan.
Researchers at Charles Drew University of Medicine and Science and UC Irvine will monitor the day-to-day health of low-birth-weight babies and their parents as part of a comprehensive initiative designed to combat chronic illnesses associated with low-weight births.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the degree of aggressiveness of the tumour in the early stages and can thus devise an individualised treatment plan.
Researchers at Charles Drew University of Medicine and Science and UC Irvine will monitor the day-to-day health of low-birth-weight babies and their parents as part of a comprehensive initiative designed to combat chronic illnesses associated with low-weight births.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Paul Berry, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 | Jonathan Paul Berry, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 |
News Archive
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
The UK Government has largely ignored lessons to be learnt from 60 years of NHS reorganisation leading to failures in the system, argues the author of a forthcoming book.
Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the degree of aggressiveness of the tumour in the early stages and can thus devise an individualised treatment plan.
Researchers at Charles Drew University of Medicine and Science and UC Irvine will monitor the day-to-day health of low-birth-weight babies and their parents as part of a comprehensive initiative designed to combat chronic illnesses associated with low-weight births.
› Verified 8 days ago
David Lee Robinson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-2252 | |
Nan Shin, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1112 S Cushman Ave, Tacoma, WA 98405 Phone: 253-593-2144 Fax: 253-280-9881 | |
Arthur L Walter, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Pediatric Extended Care Clinic, Madigan Army Medical Center, Tacoma, WA 98431 Phone: 253-968-3066 | |
Bradley Stanton Hood, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 311 S L St, Tacoma, WA 98405 Phone: 253-403-1540 | |
Kirk N. Liesemer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-3066 | |
Christopher Anthony Bellotti, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 603 S J St Ste 102, Tacoma, WA 98405 Phone: 253-396-4868 Fax: 253-396-4870 | |
Dr. Michael Timothy Alston, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 |